From Canada’s Discovery to Global Longevity Hype Could one tiny cellular pathway decide how fast we age? Discover how rapamycin and mTOR are reshaping the way we think about longevity, healthy aging, and slowing down aging with rapamycin. For deeper insights on how this drug influences lifespan, you can also explore whether rapamycin can help…

Rapamycin has long been studied as a potential rapamycin anti aging therapy—something explored in detail in resources like this longevity overview. But in 2025, the spotlight is shifting toward new and unexpected research directions—far beyond its classic role in slowing aging. Here are some of the most intriguing and lesser-known findings emerging this year, especially…

Slowing aging is no longer just science fiction. A newly published scientific study shows that a combination of two FDA-approved drugs—rapamycin and trametinib—can significantly slow down aging and extend lifespan in mice. This aligns with growing interest in FDA approved anti aging drugs and how they contribute to longevity science, as highlighted in articles like…

A Remarkable Discovery Hidden in the Soil of a Remote Island In 1964, a fascinating scientific expedition set sail from Halifax, Nova Scotia, aboard the HMCS Cape Scott. The Medical Expedition to Easter Island brought together approximately 40 doctors and scientists with an ambitious goal. They started studying the health and genetics of one of…

Rapamycin has gone from being a life-saving drug for transplant patients to one of the most intriguing candidates for slowing aging. As more research uncovers new rapamycin benefits, scientists are now exploring its role in cellular rejuvenation, metabolic repair, and even reproductive health. Beyond the headlines, new discoveries continue to shape how we think about…

For generations, menopause has been a biological inevitability—a point of no return in a woman’s life that signals not only the end of fertility but also the start of increased menopause health risks, from heart disease to osteoporosis.But what if menopause could be delayed—not indefinitely, but long enough to support early menopause prevention, better hormonal…

“How eating less (caloric restriction) and using Rapamycin might be related” “How both affect the same core biological pathway: the mTOR pathway“ Both caloric restriction (CR) and rapamycin influence the mTOR pathway, a central regulator of growth, metabolism, and aging — which is why many researchers now discuss rapamycin fasting benefits and how they compare…

Breakthrough Drug Duo Prolongs Mouse Lifespan by 30% A pioneering study from Germany’s Max Planck Institute for Biology of Aging has unveiled that a combination of two existing cancer medications—rapamycin and trametinib—can rapamycin extend lifespan in mice by approximately 30%. This discovery aligns with earlier findings on rapamycin’s longevity potential, such as those discussed in…

A potential breakthrough in feline medicine is offering new hope to cat owners and veterinarians battling hypertrophic cardiomyopathy (HCM), a leading cause of sudden death in cats. The drug rapamycin, long studied for its anti-aging properties in humans and animals, is now showing strong potential as rapamycin for cats, building on broader longevity research discussed…

The Dog Aging Project has reached an exciting milestone in its landmark dog aging study on healthy aging in dogs. The project recently announced that the first participants—Zoe and Jack—have completed their full three-year involvement in the Test of Rapamycin in Aging Dogs (TRIAD), a groundbreaking clinical trial exploring whether rapamycin for dogs can slow…